Cryopreservation of Semen Tried in Adolescent Males

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 7 No 8
Volume 7
Issue 8

NIAGARA-ON-THE-LAKE, Ontario, Canada--While the collection of sperm from adult males prior to cancer treatment is a routine matter, the same issue has not yet been regularly introduced into adolescent clinics.

NIAGARA-ON-THE-LAKE, Ontario, Canada--While the collection of sperm from adult males prior to cancer treatment is a routine matter, the same issue has not yet been regularly introduced into adolescent clinics.

"We should be prepared to offer sperm banking to patients who are about to receive chemotherapy or radiotherapy that might damage spermatogenesis," said Jørn Müller, MD, Department of Growth and Reproduction, The Juliane Marie Centre, Copenhagen, Denmark.

He noted that this has not commonly been an option for young men, "and yet the technology is available to preserve their sperm and also to use very few sperm to fertilize an egg," he said at the 5th International Conference for Long-Term Complications of Treatment of Children and Adolescents for Cancer, hosted by Roswell Park Cancer Institute.

The Danish group has examined this topic for 3 years in adolescent males. Several concerns have been addressed in the study, including the often short time between the cancer diagnosis and required therapy, the difficulty in addressing the topic with a young adult male and his parents, the large variation in physical maturation in adolescent males, and the limited experience in semen analysis and cryopreservation in adolescent males.

The researchers approached 33 families. Of these, 15 boys were able to produce semen samples for cryopreservation (via masturbation, penile vibratory stimulation, or electroejaculation).

The age range was 13 to 18 years, with a mean of 16. Each patient had a new diagnosis of cancer or relapsed disease. The group included seven patients with acute lymphoblastic leukemia, three with Hodgkin’s lymphoma, one with non-Hodgkin’s lymphoma, two with osteosar-coma, one with a central nervous system tumor, and one with Wilms’ tumor.

Semen samples from two of the boys (13 and 17 years old) did not contain spermatozoa and were not preserved. The remaining 24 samples were analyzed for volume and viable sperm.

60 Million Sperm per Sample

The median volume of semen delivered was 3.0 mL (range, 0.7 to 8.3 mL), and the median volume of sperm cryopreserved was 2.5 mL (range, 0.6 to 7.2 mL). The median number of spermatozoa in the samples was 60 million (range, 1.6 to 210 million). In comparison, a normal, fertile man would produce about 250 million spermatozoa in a similar sample.

"In the lowest age range, there was a lower number of spermatozoa as well as decreased semen volume," Dr. Müller noted.

He said that studies have shown that adolescents, even those as young as 11, may also have semen in their urine, and although these sperm are passively transmitted, this could offer another way to bank sperm for the future.

"This study shows that cryopreservation of semen in young adults is possible and suggests that the analysis of spermatogenesis in males over the age of 10 should be considered before cancer treatment. It offers these young men the possibility that they can preserve their ability to father children," Dr. Müller concluded.

Recent Videos
Certain bridging therapies and abundant steroid use may complicate the T-cell collection process during CAR T therapy.
Pancreatic cancer is projected to become the second-leading cause of cancer-related deaths by 2030 in the United States.
2 experts are featured in this video
2 experts are featured in this video
2 experts are featured in this video
4 KOLs are featured in this series.
Educating community practices on CAR T referral and sequencing treatment strategies may help increase CAR T utilization.
The FirstLook liquid biopsy, when used as an adjunct to low-dose CT, may help to address the unmet need of low lung cancer screening utilization.
Related Content